➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKinsey
Colorcon
Harvard Business School
McKesson
Dow
Mallinckrodt

Last Updated: August 3, 2020

DrugPatentWatch Database Preview

PIROXICAM Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Which patents cover Piroxicam, and what generic alternatives are available?

Piroxicam is a drug marketed by Breckenridge, Cadila, Cycle Pharms Ltd, Egis, Flamingo Pharms, Hikma Pharms, Ivax Sub Teva Pharms, Micro Labs, Mylan, Nostrum Labs Inc, SCS, Strides Pharma, Sun Pharm Industries, Teva, Teva Pharms, Unichem Labs Ltd, and Watson Labs. and is included in twenty-three NDAs.

The generic ingredient in PIROXICAM is piroxicam. There are sixteen drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the piroxicam profile page.

US ANDA Litigation and Generic Entry Outlook for Piroxicam

A generic version of PIROXICAM was approved as piroxicam by TEVA on December 11th, 1992.

  Start Trial

Drug patent expirations by year for PIROXICAM
Drug Prices for PIROXICAM

See drug prices for PIROXICAM

Drug Sales Revenue Trends for PIROXICAM

See drug sales revenues for PIROXICAM

Recent Clinical Trials for PIROXICAM

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Ain Shams UniversityEarly Phase 1
Cairo UniversityN/A
Cairo UniversityEarly Phase 1

See all PIROXICAM clinical trials

Pharmacology for PIROXICAM
Medical Subject Heading (MeSH) Categories for PIROXICAM

US Patents and Regulatory Information for PIROXICAM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs PIROXICAM piroxicam CAPSULE;ORAL 074287-002 May 16, 1996 DISCN No No   Start Trial   Start Trial   Start Trial
Teva PIROXICAM piroxicam CAPSULE;ORAL 074131-001 Dec 11, 1992 AB RX No No   Start Trial   Start Trial   Start Trial
Strides Pharma PIROXICAM piroxicam CAPSULE;ORAL 210347-002 Jan 26, 2018 AB RX No No   Start Trial   Start Trial   Start Trial
Teva PIROXICAM piroxicam CAPSULE;ORAL 073638-001 Jan 28, 1994 DISCN No No   Start Trial   Start Trial   Start Trial
Sun Pharm Industries PIROXICAM piroxicam CAPSULE;ORAL 073536-002 Jan 23, 2008 DISCN No No   Start Trial   Start Trial   Start Trial
Breckenridge PIROXICAM piroxicam CAPSULE;ORAL 208991-001 Feb 21, 2018 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
McKesson
Express Scripts
Colorcon
Boehringer Ingelheim
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.